Skip to content
Subscribe
Search
Search
Home
News
Videos
Conference Coverage
Menu
Home
News
Videos
Conference Coverage
News and Views
FDA Approves Sun Pharma’s Alopecia Drug Leqselvi: What Will this Mean for Patients?
July 29, 2024
Benjamin Ungar, MD, the Director of the Alopecia Center of Excellence at Mount Sinai in New York City, discusses what the U.S. Food and Drug Administration approval of Sun Pharma’s LEQSELVI (deuruxolitinib) will mean for adults with severe alopecia areata.
Prev
Previous
Next
Next